HLA-C and neoplasm: There might be several reasons for that including (1) low-level expression of the major MHC molecules, (2) absence of recognized tumor Ags, (3) poor costimulatory molecule expression, or (4) some kind of immunosuppression of the CD8+ T-cell response such as TGF-β [18].